Form 4 for OFIX Orthofix Medical Inc.
Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-05 · accession 0001209191-23-002670 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-09 | 2023-01-05 | OFIX | Kenny Kevin J. | Pres of Gbl Spine | A - Grant | $0.00 | +73.1K | 125.0K | +141% | $0 |
| D | 2023-01-09 | 2023-01-05 | OFIX | Kenny Kevin J. | Pres of Gbl Spine | A - Grant | $0.00 | +72.1K | 72.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-05 | A | A | 29,905 | $0.00 | 102,312 | D | — | — | (F1) The restricted stock units vest with respect to one-fourth (1/4th) of the shares of stock covered hereby on each of the first, second, third, and fourth anniversaries of the Grant Date. |
| 2 | Common | Common Stock | 2023-01-05 | A | A | 20,492 | $0.00 | 145,518 | D | — | — | (F4) Represents outstanding performance stock units for awards granted in 2022, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on January 31, 2025. (F5) Includes 124,049 unvested restricted stock units. |
| 3 | Common | Common Stock | 2023-01-05 | A | A | 10,485 | $0.00 | 112,797 | D | — | — | (F2) Represents outstanding performance stock units for awards granted in 2020, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on June 8, 2023. |
| 4 | Common | Common Stock | 2023-01-05 | A | A | 12,229 | $0.00 | 125,026 | D | — | — | (F3) Represents outstanding performance stock units for awards granted in 2021, which as a result of the Orthofix Board's determination to treat the merger with SeaSpine Holdings Corporation as a change in control (referred to as a "corporate transaction" under Orthofix's Amended and Restated 2012 Long-Term Incentive Plan) were deemed achieved at target levels as of the merger date and converted to time-based awards that vest on April 1, 2024. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2023-01-05 | A | A | 72,146 | $0.00 | 72,146 | D | $20.90 · — to 2033-01-05 | 72,146 Common Stock | (F6) The option vests in four equal installments on each of January 5, 2023, January 5, 2024, January 5, 2025 and January 5, 2026. |